# Critical Path to Public Private Partnerships

> **NIH FDA U18** · CRITICAL PATH INSTITUTE · 2022 · $18,377,119

## Abstract

PROJECT SUMMARY
C-Path was created in 2005 under the auspices of the Critical Path Initiative to catalyze
advances in medical innovation and regulatory science by leading teams of stakeholders from
academia, industry, government, and advocacy organizations and promoting the sharing of
data, knowledge and expertise in order to produce sound, consensus-based science. C-Path's
successes include the creation of cooperative consortia, the qualification of new drug
development tools (DDTs), the endorsement of fit-for-purpose disease progression models and
clinical trial simulation tools, the generation of new data standards and databases, and the
creation of educational initiatives that advance regulatory science. With renewed funding C-Path
will be able to continue developing Critical Path Public-Private Partnerships and advancing
innovative, collaborative projects in research, education, and outreach for fostering medical
product innovation, enabling the acceleration of medical product development, manufacturing,
and translational therapeutics, and enhancing medical product safety.

## Key facts

- **NIH application ID:** 10463590
- **Project number:** 5U18FD005320-09
- **Recipient organization:** CRITICAL PATH INSTITUTE
- **Principal Investigator:** Klaus Romero
- **Activity code:** U18 (R01, R21, SBIR, etc.)
- **Funding institute:** FDA
- **Fiscal year:** 2022
- **Award amount:** $18,377,119
- **Award type:** 5
- **Project period:** 2014-09-05 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10463590

## Citation

> US National Institutes of Health, RePORTER application 10463590, Critical Path to Public Private Partnerships (5U18FD005320-09). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10463590. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*